Yesterday, we received Patent News on CM24. Today we get news finally on the Phase 1 Trial, which is GREAT but no "official" name attached to it. But we KNOW this: cetuximab is owned by $LLY in US/Canada and ROW $MRK. We know, that Phase 1 NT219 is in US/Canada. So that's proof. https://t.co/WZIRQBT5cb